Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zhang, Zhou Ji ^a   Yang, Yun Ke ^a   Wu, Wei Zhong ^b  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

AKT GSK3 catenin E cadherin signaling pathways; Hepatocellular carcinoma; Orthotopic transplantation tumor models; Pulmonary metastases

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; BUFALIN; GELATINASE A; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CONTROLLED STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL; TUMOR NECROSIS; TUMOR VOLUME;

ANIMALS; APOPTOSIS; BETA CATENIN; BUFANOLIDES; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NECROSIS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84899486140     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-57     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516, 21351269.
2. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010, 3:S206-S214.
3. Kishi Y, Hasegawa K, Sugawara Y, Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol 2011, 2011:728103. 3170840, 21994868.
4. Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, Magee JC, Lok AS, Fontana RJ, Marrero JA. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 2009, 15:859-868. 10.1002/lt.21778, 19642139.
5. Wang G, Wang F, Ding W, Wang J, Jing R, Li H, Wang X, Wang Y, Ju S, Wang H. APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway. PLoS One 2013, 8:e55298. 10.1371/journal.pone.0055298, 3558491, 23383143.
6. Xue G, Hemmings BA. PKB/Akt-dependent regulation of cell motility. J Natl Cancer Inst 2013, 105:393-404. 10.1093/jnci/djs648, 23355761.
7. Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Cancer Lett 2012, 316:187-195. 10.1016/j.canlet.2011.10.037, 22182943.
8. Lin BQ, Zeng ZY, Yang SS, Zhuang CW. Dietary restriction suppresses tumor growth, reduces angiogenesis, and improves tumor microenvironment in human non-small-cell lung cancer xenografts. Lung Cancer 2013, 79:111-117. 10.1016/j.lungcan.2012.11.001, 23199512.
9. Qi F, Li A, Inagaki Y, Inagaki Y, Kokudo N, Tamura S, Nakata M, Tang W. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol 2011, 11:342-349. 10.1016/j.intimp.2010.12.007, 21185919.
10. Li D, Qu X, Hou K, Zhang Y, Dong Q, Teng Y, Zhang J, Liu Y. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs 2009, 20:59-64. 10.1097/CAD.0b013e3283160fd6, 19343001.
11. Tsai SC, Lu CC, Lee CY, Lin YC, Chung JG, Kuo SC, Amagaya S, Chen FN, Chen MY, Chan SF, Yang JS. AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells. Int J Oncol 2012, 41:1683-1692.
12. Qiu DZ, Zhang ZJ, Wu WZ, Yang YK. Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells. BMC Complement Altern Med 2013, 13:185. 10.1186/1472-6882-13-185, 3723921, 23870199.
13. Yang BW, Liang Y, Xia JL, Sun HC, Wang L, Zhang JB, Tang ZY, Liu KD, Chen J, Xue Q, Chen J, Gao DM, Wu WZ. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice. Eur J Gastroenterol Hepatol 2008, 20:1077-1084. 10.1097/MEG.0b013e3283050a67, 19047839.
14. Han KQ, Huang G, Gu W, Su YH, Huang XQ, Ling CQ. Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J Gastroenterol 2007, 13:3374-3379.
15. Liu L, Ren ZG, Shen Y, Zhu XD, Zhang W, Xiong W, Qin Y, Tang ZY. Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelial-mesenchymal transition. Cancer Sci 2010, 101:120-128. 10.1111/j.1349-7006.2009.01363.x, 19832842.
16. Wang L, Tang ZY, Qin LX, Wu XF, Sun HC, Xue Q, Ye SL. High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Hepatology 2000, 32:43-48.
17. Zhang DY, Xu ZP, Chiang H, Lu DQ, Zeng QL. Effects of GSM 1800 MHz radiofrequency electromagnetic fields on DNA damage in Chinese hamster lung cells. Zhonghua Yu Fang Yi Xue Za Zhi 2006, 40:149-152.
18. Xiang F, Yu W, Shen Y, Wu C, Wang Y. Effects of neoadjuvant chemotherapy on the quantitative expression of P-gp, LRP, MRP, GST-π in NSCLC and its clinical significance. Zhongguo Fei Ai Za Zhi 2007, 10:398-405.
19. Le LP, Dias-Santagata D, Pawlak AC, Cosper AK, Nguyen AT, Selim MA, Deng A, Horick NK, Iafrate AJ, Mihm MC, Hoang MP. Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. PLoS One 2012, 7:e47290. 10.1371/journal.pone.0047290, 3467209, 23056620.
20. Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle 2008, 7:2991-2996. 10.4161/cc.7.19.6784, 18818526.
21. Wang K, Cao F, Fang W, Hu Y, Chen Y, Ding H, Yu G. Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression. BMC Cancer 2013, 13:343. 10.1186/1471-2407-13-343, 3729721, 23848995.
22. Wang CY, Tsai AC, Peng CY, Chang YL, Lee KH, Teng CM, Pan SL. Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways. PLoS One 2012, 7:e31195. 10.1371/journal.pone.0031195, 3281050, 22359572.
23. Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, Cleary ML. Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 2008, 455:1205-1209. 10.1038/nature07284, 18806775.
24. Yan X, Lyu T, Jia N, Yu Y, Hua K, Feng W. Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway. PLoS One 2013, 8:e63731. 10.1371/journal.pone.0063731, 3648479, 23667667.
25. Fang Y, Xue JL, Shen Q, Chen J, Tian L. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012, 55:1852-1862. 10.1002/hep.25576, 22234835.
26. Niessen CM, Gottardi CJ. Molecular components of the adherens junction. Biochim Biophys Acta 2008, 1778:562-571. 10.1016/j.bbamem.2007.12.015, 2276178, 18206110.
27. Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS One 2012, 7:e31251. 10.1371/journal.pone.0031251, 3279370, 22348060.
28. Zhang CY, Zhang L, Yu HX, Bao JD, Lu RR. Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression. Biotechnol Lett 2013, 35:995-1000. 10.1007/s10529-013-1173-y, 23474829.
29. Yuan J, Wu Y, Lu G. α-Mangostin suppresses lipopolysaccharide-induced invasion by inhibiting matrix metalloproteinase-2/9 and increasing E-cadherin expression through extracellular signal-regulated kinase signaling in pancreatic cancer cells. Oncol Lett 2013, 5:1958-1964. 3700960, 23833675.
30. Li H, Huang J, Yang B, Xiang T, Yin X, Peng W, Cheng W, Wan J, Luo F, Li H, Ren G. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. Toxicol Appl Pharmacol 2013, 272:180-190. 10.1016/j.taap.2013.05.011, 23707762.